World Media Directory · RSS · Email Newsletters

There were 890 press releases posted in the last 24 hours and 169,193 in the last 365 days.

Healthcare & Pharmaceuticals Industry Press Releases

Healthcare & Pharmaceuticals Industry Press Releases Distributed by EIN Presswire

103,654 Press Releases · RSS · Email

Published on November 11, 2019 - 13:00 GMT

Data for Assembly Biosciences’ First and Second Generation HBV Core Inhibitors in Development for the Treatment of Chronic ...

ABI-H0731 + nucleos(t)ide analogs (Nrtl) in patients with chronic Hepatitis B demonstrated favorable longer-term tolerability, greater reductions in HBV DNA and HBV pregenomic (pg) RNA in Phase 2 studies than Nrtl alone Significant declines in HBV pgRNA, a …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on November 11, 2019 - 13:00 GMT

ORYZON to Present at Upcoming International Conferences

25th Annual International Partnering Conference BIO-Europe-2019, Hamburg, Germany Jefferies London Healthcare Conference, London, UK MADRID, Spain and CAMBRIDGE, Mass., Nov. 11, 2019 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), …

Distribution channels:
Published on November 11, 2019 - 12:30 GMT

MyoKardia Announces 48-week Data from PIONEER-OLE Study of Mavacamten

Mavacamten’s Safety and Efficacy Profile in the PIONEER Study Maintained Through One Year in Open-Label Extension Study of 12 Patients with Symptomatic, Obstructive HCM Evidence Suggests Mavacamten’s Favorable Impact on Cardiac Structure Conference Call …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on November 11, 2019 - 12:30 GMT

Achillion Announces Clearance of Investigational New Drug Application for ACH-5228

BLUE BELL, Pa., Nov. 11, 2019 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients and families affected by complement-mediated diseases, today …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on November 11, 2019 - 12:30 GMT

MyoKardia Announces Positive Topline Data from its Phase 2 MAVERICK-HCM Clinical Trial of Mavacamten

Achieved Primary Study Objective of Safety and Tolerability in Patients with Non-obstructive HCM Significant Reductions in Biomarkers of Cardiac Stress Observed in Patients on Treatment vs. Placebo Data Support Advancement of Mavacamten in Non-obstructive …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on November 11, 2019 - 12:30 GMT

Flexion Therapeutics Presents ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) Efficacy Data at the ...

Post-hoc sensitivity analysis assessed efficacy in patients who reported moderate-to-severe osteoarthritis (OA) pain prior to treatment on both ADP and WOMAC-A scales In this analysis of concordant pain reporters, ZILRETTA provided durable pain relief that …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on November 11, 2019 - 12:05 GMT

Myriad’s Prequel™ Prenatal Screen Demonstrates High Performance Across All Fetal-Fraction Levels in Women Undergoing Noninvasive ...

SALT LAKE CITY, Nov. 11, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN, “Myriad” or the “Company”), a global leader in molecular diagnostics and precision medicine, today announced that a new study of the Prequel™ Prenatal Screen was …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on November 11, 2019 - 12:00 GMT

Axogen, Inc. to Participate at Jefferies London Healthcare Conference

ALACHUA, Fla., Nov. 11, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced that Karen Zaderej, chairman, CEO, and …

Distribution channels:
Published on November 11, 2019 - 12:00 GMT

Aleafia Health Outdoor Harvest Yields 10,300 kg of Dried Flower at $0.08 Cost per Gram

Cannabinoid content per gram only slightly lower than identical strains grown indoors Critical quality control tests successful Approximately 1,000 kg yield per acre in Zone 1 Expanded 3.7M sq. ft. outdoor site expected to produce approximately 102,000 kg …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on November 11, 2019 - 12:00 GMT

Cara Therapeutics Announces Publication of Difelikefalin (KORSUVA™ Injection) KALM™-1 Phase 3 Trial Results in the New England ...

- Treatment with KORSUVA Injection resulted in statistically significant reduction in pruritus intensity and improvement in itch-related quality of life measures vs placebo for both primary and secondary endpoints - STAMFORD, Conn., Nov. 11, 2019 (GLOBE …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on November 11, 2019 - 11:45 GMT

Teleflex to Showcase its Interventional Portfolio Highlighting the MANTA® Vascular Closure Device and the Langston® Dual Lumen ...

WAYNE, Pa., Nov. 11, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, will showcase its Interventional product portfolio including the MANTA® Vascular Closure Device and Langston® Dual Lumen …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on November 11, 2019 - 11:30 GMT

Mereo BioPharma’s Setrusumab Demonstrates Dose-Dependent Bone Building and Trend in Fracture Reduction in Phase 2b ASTEROID Study ...

Dose-Dependent and Statistically Significant Improvement in Areal Bone Mineral Density (BMD) Over Baseline at the Lumbar Spine, as Measured by DXA, Reaching 8.8% at 12 Months in Highest Dose Cohort (p<0.001); Improvement Consistent Across All OI …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on November 11, 2019 - 11:14 GMT

Urinary Drainage Bags Market to Reach USD 1,475.60 Million by 2026; Increasing Prevalence of Bladder Cancer to Drive Growth, says ...

Pune, Nov. 11, 2019 (GLOBE NEWSWIRE) -- A rise in the geriatric population is projected to boost the global urinary drainage bags market during the forecast period. According to a published report by Fortune Business Insights, titled, “Urinary Drainage …

Distribution channels:
Published on November 11, 2019 - 11:00 GMT

Air Force Veteran is Restoring Hope to Local “U.S.A” Heroes

DALLAS, Nov. 11, 2019 (GLOBE NEWSWIRE) -- U.S. Air Force Veteran and CEO of Certified Veteran Owned Small Business (VOSB) MedWell Solutions, Keith Palmer, knows firsthand what it means to sacrifice and serve others. Through a shared vision with the …

Distribution channels:
Published on November 11, 2019 - 11:00 GMT

Foamix Reports Third Quarter 2019 Financial Results and Provides Corporate Update

REHOVOT, Israel, and BRIDGEWATER, N.J., Nov. 11, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (“Foamix” or the “Company”), a specialty pharmaceutical company focused on developing and commercializing proprietary topical therapies to …

Distribution channels:
Published on November 11, 2019 - 11:00 GMT

Foamix and Menlo Therapeutics to Merge, Creating a Combined Company Focused on the Development and Commercialization of ...

Combination establishes a dermatology-focused company with a broad portfolio of an approved product and late-stage dermatology assets Menlo’s serlopitant for pruritus associated with prurigo nodularis (“PN”) complements Foamix’s existing portfolio and …

Distribution channels:
Published on November 11, 2019 - 10:00 GMT

Amarin to Present at the Jefferies 2019 London Healthcare Conference

DUBLIN, Ireland and BRIDGEWATER, N.J., Nov. 11, 2019 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on improving cardiovascular health announced today that John F. Thero, Amarin's president and chief …

Distribution channels:
Published on November 11, 2019 - 08:21 GMT

ASLAN Pharmaceuticals Announces Topline Results From TreeTopp Global Pivotal Study of Varlitinib in Biliary Tract Cancer

- The study did not meet its co-primary endpoints. The primary analysis of PFS yielded a hazard ratio of 0.90 in favour of varlitinib, and the ORR for varlitinib was 9.4% versus 4.8% in the control arm. These were not significant at the pre-specified …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on November 11, 2019 - 08:00 GMT

Cancer Advances, Inc. announces a new publication “Vaccine Against Gastrin, a Polyclonal Antibody Stimulator, Decreases Pancreatic ...

Immune competent female mice with pancreatic cancer treated with Polyclonal Antibody Stimulator (PAS) vaccine had significantly smaller tumors and fewer metastases than control mice. PAS vaccine decreased metastasis by decreasing key pathway proteins …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on November 11, 2019 - 07:55 GMT

General Electric Appoints Selam Amare as Country Leader for Ethiopia

General Electric (GE) (http://www.GE.com) has announced the appointment of Selam Amare as the Country Leader for Ethiopia. In this role, Selam will oversee GE’s operations in the country and strengthen our businesses presence in the market. She will also …

Distribution channels: Aviation & Aerospace Industry, Business & Economy ...

Previous 4 5 6 7 8 9 10 11 12 13 14 Next

EIN Presswire

Back to top

Quick Links:

Resources:

Press Releases:

Featured Clients:

Help & Information Center:

EIN News Home
About EIN News

Founded in 1995, EIN News is an international leader in real-time news tracking and digital information services. Our systems continuously scan the web, indexing news from thousands of worldwide sources. The data is then filtered and organized into news streams. The process is supervised by a team of professional news editors.

We are news professionals and technologists dedicated to producing the fastest and most comprehensive news streams on the planet. We are committed to providing our members with the highest quality software tools and resources available.

EIN News is a division of Internet Product Development Group Inc.
To reach us send an email or call +1 (202) 335-3939.
EIN Presswire
Events & Conferences
Newsfeed Maker
Inbox Robot
IPD Group
EIN Twitter
EIN Facebook